BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37717471)

  • 1. HSP90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma.
    Zhang J; Liu L; Li Y; Huang Y; Xiao S; Deng Z; Zheng Z; Li J; Liang M; Xie G; Chen X; Deng Y; Tan W; Su H; Wu G; Cai C; Chen X; Zou F
    Neoplasia; 2023 Oct; 44():100935. PubMed ID: 37717471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
    Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific ubiquitination of VDAC1 restricts its oligomerization and mitochondrial DNA release in liver fibrosis.
    Wu NN; Wang L; Wang L; Xu X; Lopaschuk GD; Zhang Y; Ren J
    Exp Mol Med; 2023 Jan; 55(1):269-280. PubMed ID: 36658227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
    Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
    J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
    Shoshan-Barmatz V; Keinan N; Abu-Hamad S; Tyomkin D; Aram L
    Biochim Biophys Acta; 2010; 1797(6-7):1281-91. PubMed ID: 20214874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
    Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
    Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinocetone induces mitochondrial apoptosis in HepG2 cells through ROS-dependent promotion of VDAC1 oligomerization and suppression of Wnt1/β-catenin signaling pathway.
    Yang X; Tang S; Dai C; Li D; Zhang S; Deng S; Zhou Y; Xiao X
    Food Chem Toxicol; 2017 Jul; 105():161-176. PubMed ID: 28343033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
    Keinan N; Pahima H; Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity.
    Arbel N; Shoshan-Barmatz V
    J Biol Chem; 2010 Feb; 285(9):6053-62. PubMed ID: 20037155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision between mitophagy and apoptosis by Parkin via VDAC1 ubiquitination.
    Ham SJ; Lee D; Yoo H; Jun K; Shin H; Chung J
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4281-4291. PubMed ID: 32047033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein.
    Arbel N; Ben-Hail D; Shoshan-Barmatz V
    J Biol Chem; 2012 Jun; 287(27):23152-61. PubMed ID: 22589539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative VDAC1 mutants reveal oligomeric VDAC1 to be the active unit in mitochondria-mediated apoptosis.
    Mader A; Abu-Hamad S; Arbel N; Gutiérrez-Aguilar M; Shoshan-Barmatz V
    Biochem J; 2010 Jul; 429(1):147-55. PubMed ID: 20420578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.
    Ben-Hail D; Begas-Shvartz R; Shalev M; Shteinfer-Kuzmine A; Gruzman A; Reina S; De Pinto V; Shoshan-Barmatz V
    J Biol Chem; 2016 Nov; 291(48):24986-25003. PubMed ID: 27738100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis.
    Shoshan-Barmatz V; Krelin Y; Chen Q
    Curr Med Chem; 2017; 24(40):4435-4446. PubMed ID: 28618997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding.
    Abu-Hamad S; Zaid H; Israelson A; Nahon E; Shoshan-Barmatz V
    J Biol Chem; 2008 May; 283(19):13482-90. PubMed ID: 18308720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VDAC upregulation and αTAT1‑mediated α‑tubulin acetylation contribute to tanespimycin‑induced apoptosis in Calu‑1 cells.
    Wang Q; Liu X
    Oncol Rep; 2020 Dec; 44(6):2725-2734. PubMed ID: 33125132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mitochondrial VDAC1 oligomerization alleviates apoptosis and necroptosis of retinal neurons following OGD/R injury.
    Wan H; Yan YD; Hu XM; Shang L; Chen YH; Huang YX; Zhang Q; Yan WT; Xiong K
    Ann Anat; 2023 Apr; 247():152049. PubMed ID: 36690044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DYNLT1 promotes mitochondrial metabolism to fuel breast cancer development by inhibiting ubiquitination degradation of VDAC1.
    Huang L; Wei B; Zhao Y; Gong X; Chen L
    Mol Med; 2023 Jun; 29(1):72. PubMed ID: 37280526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
    Shoshan-Barmatz V; Mizrachi D; Keinan N
    Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.